Showing results (21-30 of 195) with videos related to
Sort By:
Pageof 20
Circulation|June 23, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.JAMA Cardiology|February 4, 2026
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.Journal of Virology|August 7, 2002
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infectionTheodore C Pierson, Yan Zhou, Tara L Kieffer, et al.Nature Medicine|December 7, 2021
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trialChristian T Ruff, Michelle Baron, KyungAh Im, et al.Journal of Virology|March 22, 2002
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replicationTheodore C Pierson, Tara L Kieffer, Christian T Ruff, et al.European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.Journal of the American College of Cardiology|June 11, 2025
Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71Siddharth M Patel, Robert P Giugliano, David A Morrow, et al.The New England Journal of Medicine|January 22, 2025
Abelacimab versus Rivaroxaban in Patients with Atrial FibrillationChristian T Ruff, Siddharth M Patel, Robert P Giugliano, et al.The American Journal of Medicine|November 3, 2007
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarctionChristian T Ruff, Stephen D Wiviott, David A Morrow, et al.Pageof 20